Loading fund overlap…
8 of 182 unique stocks in common · Jaccard: 4.4%
A weighted portfolio overlap of 9.26% indicates a low overlap (mostly different holdings). This means that out of every ₹100 you invest across these two schemes, approximately ₹9.26 is allocated to the exact same companies at the same relative proportions. The schemes share 8 common holdings.
The largest overlapping asset in their portfolios is Fortis Healthcare, which commands a weight of 3.43% in Back to Index and 4.03% in Kotak Midcap Fund. Holding both schemes increases your concentration in Fortis Healthcare rather than expanding your diversification.
If the overlap is above 30%, it is typically because both schemes benchmark to the same index (e.g. Nifty 50 or Nifty LargeMidcap 250) or overlap in their top large-cap picks. To improve your portfolio's diversification, consider allocating one of these tranches to a category with lower structural correlation (such as a mid-cap, small-cap, or international equity fund).
| Stock | in Back | in Kotak |
|---|---|---|
| Fortis HealthcareHealthcare Services | 3.43% | 4.03% |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | 1.52% | 2.91% |
| JB Chemicals & PharmaceuticalsPharmaceuticals & Biotechnology | 1.22% | 1.61% |
| Aster DM HealthcareHealthcare Services | 1.32% | 0.89% |
| Max Healthcare InstituteHealthcare Services | 5.23% | 0.80% |
| Global HealthHealthcare Services | 0.66% | 1.63% |
| Apollo Hospitals EnterpriseHealthcare Services | 5.55% | 0.57% |
| Rubicon ResearchPharmaceuticals & Biotechnology | 0.17% | 0.59% |
Weighted overlap = Σ min(weight in fund A, weight in fund B) across shared stocks, from each fund's latest public monthly portfolio (as on May 2026). Equity holdings only, ISIN-verified. Not investment advice.